(NPS) Why child-resistant packaging doesn’t mean child-proof http://t.co/kkPCpiHbAJ pic.twitter.com/F2WH40Yn7q #PtSafety
— Sano y salvo (@sanoysalvoblog) February 10, 2014
MT @GM_PSTRC Our 1st newsletter on #patientsafety in #primarycare http://t.co/yKWBsQKIyv @meds_safety @Multimorbidity #PtSafety
— Sano y salvo (@sanoysalvoblog) February 11, 2014
Is #polypharmacy always hazardous?A retrospective cohort analysis. British Journal of Clinical Pharmacology http://t.co/uvXpE0JWwq #PtSafety
— Sano y salvo (@sanoysalvoblog) February 11, 2014
Saxagliptin (marketed as Onglyza & Kombiglyze XR): Drug Safety Communication - FDA to Review Heart Failure Risk http://t.co/tXl1Mx8OcL #FDA
— US FDA MedWatch (@FDAMedWatch) February 11, 2014
Recursos en español sobre uso seguro de paracetamol (acetaminofén en USA) para pacientes http://t.co/cTZuvRRXLx por @KnowYourDose #SegPac
— Sano y salvo (@sanoysalvoblog) February 11, 2014
@GM_PSTRC There are very few sites dedicated to patient safety in primary care on the Internet: the more the merrier! ;) #PtSafety @je_pala
— Sano y salvo (@sanoysalvoblog) February 12, 2014
Nueva evidencia vuelve a poner en duda beneficios de screening mamográfico http://t.co/UyiJpqyQTJ vía @Overdiagnosis
— Médicos Sin Marca (@MedicosSinMarca) February 12, 2014
FDA requires removal of some prescribing and dispensing restrictions for rosiglitazone-containing diabetes medicines http://t.co/sau5nRfnQ3
— Sano y salvo (@sanoysalvoblog) February 12, 2014
Anticholinergics and sedatives in older people — managing the risks http://t.co/kDFZNsr9dt #PtSafety
— Sano y salvo (@sanoysalvoblog) February 12, 2014
A Global Problem: Highlight from Battling Drug-Resistant Superbugs #Antibiotics #PtSafety http://t.co/BjyyrCL1P4 @HarvardHSPH v @2gespetites
— Sano y salvo (@sanoysalvoblog) February 12, 2014
Changing the trajectory of burnout in medicine: protecting patients and physicians http://t.co/VDkhGGhJuf #PtSafety
— Sano y salvo (@sanoysalvoblog) February 12, 2014
Cuantos más especialistas tratan a un paciente, mayor riesgo de que sufra un evento adverso #SegPac http://t.co/NzYtmIntAa v @EnferEvidente
— Sano y salvo (@sanoysalvoblog) February 12, 2014
Análisis de causas raíz (ACR) de eventos adversos, cómo no empezarlos:"yo no he tenido la culpa" #SegPac v @MedChiefs pic.twitter.com/PiBol6cnk2
— Sano y salvo (@sanoysalvoblog) February 12, 2014
(Hemos Leído) Saxagliptina y posible riesgo de insuficiencia cardíaca http://t.co/5OxQoPuP0d #SegPac
— Sano y salvo (@sanoysalvoblog) February 12, 2014
Highly Educated and Underutilized: Pharmacists Need to Be More Involved in Drug Safety http://t.co/bVCuu0SGya #PtSafety
— Sano y salvo (@sanoysalvoblog) February 12, 2014
Pradaxa fatal bleeding. New Emails in Pradaxa Case Show Concern Over Profit http://t.co/ekKPW1JueO vía @JuanGrvas #PtSafety
— Sano y salvo (@sanoysalvoblog) February 12, 2014
Crisis económica y vulnerabilidad social en personas mayores. Ancianos frágiles. Aten Primaria http://t.co/4OVhqSDtDR #SegPac
— Sano y salvo (@sanoysalvoblog) February 13, 2014
Metodología de conciliación del tratamiento farmacológico en pacientes pluripatológicos. Aten Primaria http://t.co/51dOCUtoB9 #SegPac
— Sano y salvo (@sanoysalvoblog) February 13, 2014
De la responsabilidad profesional médica a la seguridad clínica. Aten Primaria http://t.co/1ahTMPu4eO #SegPac
— Sano y salvo (@sanoysalvoblog) February 13, 2014
Too much medicine. Less is more - http://t.co/MLec7E16pG via @JuanGrvas #PtSafety #VdGMForum
— Sano y salvo (@sanoysalvoblog) February 13, 2014
Have a cold? Be sure you’re not double dosing acetaminophen, it’s easy to make the mistake. Learn more here http://t.co/zsMu3Vt6n1 #ptsafety
— Safe Medication Use (@SafeMedUse) February 13, 2014
“@cecilicp: Retirada de estatinas en pacientes ancianos http://t.co/BMtVX5zsXV #desprescripción” #SegPac
— Sano y salvo (@sanoysalvoblog) February 13, 2014
Exposure to Oral Fluoroquinolones and the Risk of Retinal Detachment: observational study http://t.co/M439Gbq5dM #PtSafety
— Sano y salvo (@sanoysalvoblog) February 14, 2014
*El equipo que mantiene @sanoysalvoblog está compuesto por Cecilia Calvo Pita @cecilicp y Jesús Palacio Lapuente @je_pala.
Realiza la publicación de estas selecciones Txema Coll Benejam @txemacoll.
No hay comentarios:
Publicar un comentario